Q4 and FY consensus estimates
Estimates for Q4 and FY 2020/21 based on median.
| Q4 2020/21 | FY 2020/21 | |||||||
| DKKm | Low | Consensus | High | Low | Consensus | High | ||
| Revenue | 1,027 | 1,027 | 1,028 | 4,014 | 4,014 | 4,014 | ||
| Gross profit | 515 | 612 | 640 | 2,408 | 2,505 | 2,533 | ||
| Gross margin | 50.2% | 59.6% | 62.3% | 60.0% | 62.4% | 63.1% | ||
| EBIT before special items | 5 | 16 | 23 | 341 | 356 | 360 | ||
| EBIT margin before special items | 0.5% | 1.6% | 2.3% | 8.5% | 8.8% | 9.0% | ||
| Net profit | -33 | -13 | 14 | 215 | 236 | 264 | ||
| Net profit margin | -3.2% | -1.2% | 1.4% | 5.4% | 5.9% | 6.6% | ||
| Endoscopes sold (units) | 389,596 | 390,000 | 391,000 | 1,524,596 | 1,525,000 | 1,526,000 | ||
| Organic growth | 17.7% | 18.0% | 18.1% | 16.0% | 16.2% | 16.4% |
29 October 2021, based on estimates from 9 analysts.
